Symbol="KDNY"
AssetType="Common Stock"
Name="Chinook Therapeutics Inc"
Description="Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision drugs for kidney disease. The company is headquartered in Seattle, Washington."
CIK="1435049"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="740 HEINZ AVENUE, BERKELEY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2701424000"
EBITDA="-197027008"
PERatio="None"
PEGRatio="None"
BookValue="6.17"
DividendPerShare="0"
DividendYield="0"
EPS="-3.24"
RevenuePerShareTTM="0.078"
ProfitMargin="0"
OperatingMarginTTM="-38.44"
ReturnOnAssetsTTM="-0.235"
ReturnOnEquityTTM="-0.516"
RevenueTTM="5259000"
GrossProfitTTM="-135083000"
DilutedEPSTTM="-3.24"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.322"
AnalystTargetPrice="40.3"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="27.9"
PriceToBookRatio="3.057"
EVToRevenue="19.67"
EVToEBITDA="-11.5"
Beta="0.673"
num_52WeekHigh="40.47"
num_52WeekLow="18.34"
num_50DayMovingAverage="34.91"
num_200DayMovingAverage="25.87"
SharesOutstanding="67050000"
DividendDate="2020-10-02"
ExDividendDate="None"
symbol="KDNY"
open="40.26"
high="40.30"
low="40.25"
price="40.28"
volume="1315231.00"
latest_trading_day="2023-08-04"
previous_close="40.29"
change="-0.01"
change_percent="-0.0248%"
aroon_positive_momentum_days="46"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Trending Low"
value_analysis="Bearish Trend"
Aroon_change="FALSE"
Aroon_momentum="46"
Volume_recent_avg="1332547"
Change_recent_avg="0.02"
Delta_recent_avg="0.77"
Variance_recent_avg="0.39"
Change_ratio_recent_avg="0.04"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="46"
Aroon_momentum_negative="54"
image_negative_thumbnail_id_1="1106"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0139.jpeg"
image_negative_thumbnail_id_2="491"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0114.jpeg"
image_neutral_thumbnail_id_1="562"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_neutral_thumbnail_id_2="570"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0029.jpeg"
image_positive_thumbnail_id_1="992"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0154.jpeg"
image_positive_thumbnail_id_2="675"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0033.jpeg"
image_professor_thumbnail_id_1="1203"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
image_professor_thumbnail_id_2="1192"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
